Clinical Trial Update: S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer [Phase 3]

View source ↗

Summary

The SWOG S9623 Phase 3 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for women with breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED